Business
Aurora Cannabis Inc. Announces C$34 Million Bought Deal Financing Intends to Repay Remaining Convertible Debt Balance
Aurora Cannabis Inc. Announces C$34 Million Bought Deal Financing Intends to Repay Remaining Conv...
About this update from Aurora Cannabis Inc.
[{"type":"text","content":"\n \n \n \n Aurora Cannabis Inc. Announces C$34 Million Bought Deal Financing Intends to Repay Remaining Convertible Debt Balance\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntar{\nTEXT-ALIGN: RIGHT\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN\n \n THE UNITED STATES\n \n /\n \n \n \n NASDAQ | TSX: ACB\n \n \n \n EDMONTON, AB\n \n ,\n \n \n Sept. 28, 2023\n \n \n /CNW/ - Aurora Cannabis Inc. (\"Aurora\" or the \"Company\") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has entered into an agreement pursuant to which Canaccord Genuity has agreed to buy, on a bought deal basis, 46,250,000 common shares of the Company (the \"Offered Securities\") at a price of\n \n C$0\n \n .73 per Offered Security (the \"Offering Price\"), for aggregate gross proceeds to Aurora of approximately\n \n C$33,762,500\n \n (the \"Offering\").\n \n \n Aurora has also granted Canaccord Genuity an option (the \"Over-Allotment Option\") to purchase up to 6,937,500 additional common shares of the Company on the same terms as the Offering. If the Over-Allotment Option is exercised in full, the aggregate gross proceeds of the Offering will be approximately\n \n C$38,826,875\n \n .\n \n \n The Company plans to use the net proceeds of the Offering to repay the remainder of its outstanding convertible senior notes at or prior to maturity, representing principal outstanding of approximately\n \n US$25 million\n \n , with the remainder, if any, to be used for strategic purposes, including potential acquisitions.\n \n \n The closing of the Offering is expected to take place on or about\n \n October 3, 2023\n \n and will be subject to customary conditions, including approvals of the Toronto Stock Exchange.\n \n \n A prospectus supplement (the \"Prospectus Supplement\") to the Company's short form base shelf prospectus dated\n \n April 27, 2023\n \n (the \"Base Shelf Prospectus\") will be filed with th...